TY - JOUR
T1 - Correction to
T2 - Nickel-catalyzed enantioselective reductive cross-coupling of styrenyl aziridines (Journal of the American Chemical Society (2017) 139 (5688-5691) DOI: 10.1021/jacs.7b03448)
AU - Woods, Brian P.
AU - Orlandi, Manuel
AU - Huang, Chung Yang Dennis
AU - Sigman, Matthew S.
AU - Doyle, Abigail G.
N1 - Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/6/20
Y1 - 2018/6/20
N2 - Table of Contents. The enantiomer of the BiOx ligand that delivers the indicated absolute configuration of product is (R,R)-(4-heptyl)BiOx. The corrected graphic is shown below: Page 5690. The absolute configuration of ligand L7 (4-heptyl- BiOx) was misassigned. The updated assignment requires corrections to Figure 2 and Table 3. The (S)-enantiomer of cross-coupled product 7 is obtained using the (S,S)-series of BiOx ligands. The corrected Figure 2 is given here. Page 5690. (R,R)-L7, not (S,S)-L7, was used for the scope studies in Table 3. The corrected Table 3 is shown here. We thank the Reisman laboratory for sharing information leading to this reassignment. (Figure Presented). Supporting Information. Page S2. The (R,R)- not the (S,S)-BiOx ligands L7-L9 were used for the studies in Figure S1. Pages S4 and S5. (R,R)-L7, not (S,S)-L7, was used for the scope studies in Tables S1, S2, and S4. Page S8. The (S)-enantiomer of cross-coupled product 7 is obtained using the (S,S)-L7 ligand in Scheme S5. Pages S12 and S13. The absolute configurations of structures S2-S5 have been corrected.
AB - Table of Contents. The enantiomer of the BiOx ligand that delivers the indicated absolute configuration of product is (R,R)-(4-heptyl)BiOx. The corrected graphic is shown below: Page 5690. The absolute configuration of ligand L7 (4-heptyl- BiOx) was misassigned. The updated assignment requires corrections to Figure 2 and Table 3. The (S)-enantiomer of cross-coupled product 7 is obtained using the (S,S)-series of BiOx ligands. The corrected Figure 2 is given here. Page 5690. (R,R)-L7, not (S,S)-L7, was used for the scope studies in Table 3. The corrected Table 3 is shown here. We thank the Reisman laboratory for sharing information leading to this reassignment. (Figure Presented). Supporting Information. Page S2. The (R,R)- not the (S,S)-BiOx ligands L7-L9 were used for the studies in Figure S1. Pages S4 and S5. (R,R)-L7, not (S,S)-L7, was used for the scope studies in Tables S1, S2, and S4. Page S8. The (S)-enantiomer of cross-coupled product 7 is obtained using the (S,S)-L7 ligand in Scheme S5. Pages S12 and S13. The absolute configurations of structures S2-S5 have been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85048881795&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048881795&partnerID=8YFLogxK
U2 - 10.1021/jacs.8b05650
DO - 10.1021/jacs.8b05650
M3 - Comment/debate
C2 - 29889505
AN - SCOPUS:85048881795
SN - 0002-7863
VL - 140
SP - 7744
EP - 7745
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 24
ER -